United States · FDA National Drug Code directory
Raloxifene hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71209-082_14d4c334-b49d-4479-a91e-20b7276b4eca
- Product NDC
- 71209-082
- Form
- TABLET, COATED
- Composition / generic term
- Raloxifene hydrochloride
- Labeler
- Cadila Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171230
- Source listing expiry
- 20261231
Source-listed ingredients
- RALOXIFENE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, COATED in 1 BOTTLE (71209-082-01) · 71209-082-01
- 100 TABLET, COATED in 1 BOTTLE (71209-082-05) · 71209-082-05
- 1000 TABLET, COATED in 1 BOTTLE (71209-082-11) · 71209-082-11
- 2000 TABLET, COATED in 1 BOTTLE (71209-082-13) · 71209-082-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →